Business News›Industry›Healthcare/Biotech›Biotech›There is compelling need to focus on Biosimilar from govt, patients' point of view: Kiran Mazumdar-Shaw
There is compelling need to focus on Biosimilar from govt, patients' point of view: Kiran Mazumdar-Shaw
There is a compelling need to focus on Biosimilar from govt and patients' point of view. Biocon and Mylan are leading the way along with few others in the Biosimilars segment, says Kiran Mazumdar-Shaw of Biocon limited.
Read more on
33:40- 23:54
Beat Diabetes With Lifestyle Modification
Views: 4906 - 06:24
- 05:17
- 01:11
- 02:39
- 06:30
- 01:34
- 01:40
- 04:12
- 02:47
- 03:12
- 02:38
- 06:02
- 11:10
- 02:29
- 05:56
- 04:04
- 06:13
- 08:57
- 04:50
- 06:32
- 09:17
- 05:57
Related Videos
